Literature DB >> 24917724

The progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma: a case report.

Catharine A Dhaliwal1, Paul W Fineron1.   

Abstract

Nephrogenic metaplasia (or nephrogenic adenoma) and clear cell adenocarcinoma of the bladder are uncommon lesions that cause diagnostic dilemmas for pathologists due to their similar morphologic features. Nephrogenic metaplasia describes a lesion in the lower urinary tract that is composed of small tubules resembling renal medullary tubules. It has been suggested that nephrogenic metaplasia may progress to clear cell adenocarcinoma but this possibility is not widely accepted. We present a case of clear cell adenocarcinoma of the bladder arising from nephrogenic metaplasia and discuss the evidence behind the association of these two distinct rare lesions.

Entities:  

Keywords:  Adenocarcinoma; Bladder; Nephrogenic adenoma; Nephrogenic metaplasia

Year:  2012        PMID: 24917724      PMCID: PMC3783325          DOI: 10.1159/000343520

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  6 in total

1.  Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma.

Authors:  Arndt Hartmann; Kerstin Junker; Wolfgang Dietmaier; Sören Schröder; Diego Lopez; Ferdinand Hofstädter; Hagen Blaszyk
Journal:  Hum Pathol       Date:  2005-11-28       Impact factor: 3.466

2.  Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.

Authors:  M Z Gilcrease; R Delgado; F Vuitch; J Albores-Saavedra
Journal:  Hum Pathol       Date:  1998-12       Impact factor: 3.466

3.  Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.

Authors:  V Tse; M Khadra; D Eisinger; A Mitterdorfer; J Boulas; J Rogers
Journal:  Urology       Date:  1997-11       Impact factor: 2.649

4.  Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?

Authors:  L Cheng; J C Cheville; T J Sebo; J N Eble; D G Bostwick
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

5.  Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?

Authors:  Guo-Xia Tong; Erin M Weeden; Diane Hamele-Bena; Youming Huan; Pamela Unger; Lorenzo Memeo; Kathleen O'Toole
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

6.  Glucocorticoid therapy and risk of bladder cancer.

Authors:  K Dietrich; A Schned; J Fortuny; J Heaney; C Marsit; K T Kelsey; M R Karagas
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

  6 in total
  1 in total

1.  Nephrogenic adenoma of the bladder: a single institution experience assessing clinical factors.

Authors:  Yooni Yi; Angela Wu; Anne P Cameron
Journal:  Int Braz J Urol       Date:  2018 May-Jun       Impact factor: 1.541

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.